Dow Up 0.53% Nasdaq Up 0.37%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
7.23 Down 0.10(1.36%) 12:14PM EDT - Nasdaq Real Time Price
Prev Close:7.33
Open:7.26
Bid:7.23 x 1800
Ask:7.26 x 200
1y Target Est:12.89
Beta:1.97
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:7.06 - 7.41
52wk Range:6.04 - 13.64
Volume:236,910
Avg Vol (3m):1,162,950
Market Cap:313.62M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 1.36%313.62M
BAXUp 0.39%40.54B
CFNUp 0.37%9.42B
HSPUp 0.11%8.92B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.09
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback